Oki Mark K 4
4 · AYTU BIOPHARMA, INC · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Oki Mark K
Chief Financial Officer
Transactions
- Award
Common Shares
2022-01-17+100,000→ 100,000 total
Footnotes (1)
- [F1]Restricted share grant. One-third of the restricted shares shall vest on January 17, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/12th of the original grant, with full vesting on January 17, 2025.